KRISTEN HEBERT: Open Payments
NPI 1093268963 · ZACHARY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,484 in 200 payments from 21 companies in 2025. Trend: 2023 $5,535 · 2024 $4,124 · 2025 $11,484
Speaker / faculty: $7,050Food & beverage: $4,255Education: $179
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 19 | $7,329 |
| ABBVIE INC. | 40 | $647 |
| UCB, Inc. | 15 | $546 |
| Janssen Biotech, Inc. | 11 | $485 |
| PFIZER INC. | 14 | $332 |
| Regeneron Healthcare Solutions, Inc. | 10 | $299 |
| Arcutis Biotherapeutics, Inc. | 14 | $280 |
| Lilly USA, LLC | 10 | $246 |
| LEO Pharma Inc. | 21 | $201 |
| Incyte Corporation | 11 | $197 |
Products named: NEMLUVIO, Bimzelx, TREMFYA, DUPIXENT, SKYRIZI, CIBINQO, Zoryve, TALTZ.
Industry payments across LA — which companies pay providers there.
